Retail sale of pharmaceutical products
NORWEGIAN PHARMACY AS
Revenue 2025
NOK 86.3m
Operating profit
NOK −3.7m
Equity
NOK 203,000
Incorporated
2019
Employees
26
Share capital
NOK 30,000
Key figures · 2025
Current ratio
0.93
Equity ratio
1.3%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -4.3% | |
| Net margin (%%) | -4.3% | |
| Return on assets (%%) | -24.4% | |
| Likviditet | ||
| Current ratio | 0.93 | |
| Working capital | −1.0m | |
| Soliditet | ||
| Equity ratio (%%) | 1.3% | |
| Debt-to-equity ratio | 73.63 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.